<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="pattern recognition receptors, namely the Toll-like receptors (TLRs) and the" exact="retinoic acid" post="inducible gene I (RIG-I)-like receptors (RLRs). These receptors recognize"/>
 <result pre="In the cytosol the virus may be recognized by the" exact="retinoic acid" post="inducible receptor (RIG)-I or the melanoma differentiation-associated protein (MDA)5."/>
 <result pre="therapeutic options, namely remdesivir, lopinavir/ritonavir with and without IFN-Î², and" exact="chloroquine" post="or hydroxychloroquine (171). Remdesivir, already early suggested to be"/>
 <result pre="namely remdesivir, lopinavir/ritonavir with and without IFN-Î², and chloroquine or" exact="hydroxychloroquine" post="(171). Remdesivir, already early suggested to be the most"/>
 <result pre="most promising compound (172, 173), is a pro-drug of an" exact="adenosine" post="nucleotide analog, which upon incorporation in the growing RNA"/>
 <result pre="licensed for HIV treatment (184, 185), as well as for" exact="chloroquine" post="and hydroxychloroquine presently used in the treatment of malaria"/>
 <result pre="HIV treatment (184, 185), as well as for chloroquine and" exact="hydroxychloroquine" post="presently used in the treatment of malaria and autoimmune"/>
 <result pre="in vivo benefits of lopinavir/ritonavir (188). Similarly, clinical trials on" exact="chloroquine" post="and hydroxychloroquine have identified methodological limitations and conflicting results,"/>
 <result pre="benefits of lopinavir/ritonavir (188). Similarly, clinical trials on chloroquine and" exact="hydroxychloroquine" post="have identified methodological limitations and conflicting results, even suggesting"/>
 <result pre="limitations and conflicting results, even suggesting a negative effect of" exact="hydroxychloroquine" post="(189â€&quot;195). In May 2020, a multinational analysis reported the"/>
 <result pre="In May 2020, a multinational analysis reported the use of" exact="hydroxychloroquine" post="or chloroquine, with or without a macrolide, for treatment"/>
 <result pre="Notably, the study was retracted shortly after publication, whereas the" exact="hydroxychloroquine" post="studies currently continue after evaluation of the safety data"/>
 <result pre="host are also potentially valuable treatment options. Interestingly, the agent" exact="camostat" post="mesylate has been reported to block the cellular serine"/>
 <result pre="Biol Chem. (2020) 295: 4773â€&quot;9. 10.1074/jbc.AC120.01305632094225 175.WangMCaoRZhangLYangXLiuJXuMet al.. Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome Coronavirus"/>
 <result pre="382:1787â€&quot;99. 10.1056/NEJMc200804332187464 189.BorbaMGSValFFASampaioVSAlexandreMAAMeloGCBritoMet al.Effect of high vs low doses of" exact="chloroquine" post="diphosphate as adjunctive therapy for patients hospitalized with severe"/>
 <result pre="JAMA Netw Open. (2020) 3:e20885710.1001/jamanetworkopen.2020.8857 190.MahevasMTranVTRoumierMChabrolAPauleRGuillaudCet al.. Clinical efficacy of" exact="hydroxychloroquine" post="in patients with covid-19 pneumonia who require oxygen: observational"/>
 <result pre="data. BMJ. (2020) 369:m1844. 10.1136/bmj.m184432409486 191.BoulwareDRPullenMFBangdiwalaASPastickKALofgrenSMOkaforECet al.A randomized trial of" exact="hydroxychloroquine" post="as postexposure prophylaxis for Covid-19. N Engl J Med."/>
 <result pre="[Epub ahead of print]. 10.1056/NEJMoa2016638. 192.GelerisJSunYPlattJZuckerJBaldwinMHripcsakGet al.. Observational study of" exact="hydroxychloroquine" post="in hospitalized patients with Covid-19. N Engl J Med."/>
 <result pre="J Med. (2020) 382:2411â€&quot;8. 10.1056/NEJMoa201241032379955 193.RosenbergESDufortEMUdoTWilberschiedLAKumarJTesorieroJet al.Association of treatment with" exact="hydroxychloroquine" post="or azithromycin with in-hospital mortality in patients with COVID-19"/>
 <result pre="(2020) 382:2411â€&quot;8. 10.1056/NEJMoa201241032379955 193.RosenbergESDufortEMUdoTWilberschiedLAKumarJTesorieroJet al.Association of treatment with hydroxychloroquine or" exact="azithromycin" post="with in-hospital mortality in patients with COVID-19 in New"/>
 <result pre="JAMA. (2020). [Epub ahead of print]. 10.1001/jama.2020.8630. 194.GautretPLagierJCParolaPHoangVTMeddebLMailheMet al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="chloroquine. J Mol Cell Biol. (2020) 12:322â€&quot;5. 10.1093/jmcb/mjaa01432236562 196.MehraMRDesaiSSRuschitzkaFPatelANHydroxychloroquine or" exact="chloroquine" post="with or without a macrolide for treatment of COVID-19:"/>
 <result pre="protocol for a randomized controlled trial on the assessment of" exact="camostat" post="treatment in chronic pancreatitis (TACTIC). Trials. (2019) 20:501. 10.1186/s13063-019-3606-y31412955"/>
</results>
